Announcements Trials
Browse Landscape

Phase

Phase 1 77Phase 2 38Phase 1/2 25Phase NA 4Phase 3 4Phase 2/3 1

Status

Completed 4Withdrawn 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Thoracic 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms, Male 2Breast Neoplasms 2Lung Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Completed × Vorinostat × Clear all
NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

University of Washington

Phase NA Completed
15 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

University of Washington

Phase NA Completed
8 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00735826 2018-10-12

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
10 enrolled 7 charts
GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms

NCT01342757 2018-01-29

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

National Cancer Institute (NCI)

Phase NA Completed
12 enrolled 8 charts
CNS

Brain Neoplasms, Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡